This section keeps you up-to-date on the latest news and upcoming public appearances of Lavery professionals.
News
-
Lavery assists Agile MV Inc. in the sale of all of its shares to Resonetics
On June 13, 2022, Resonetics announced the purchase of the entirety of the shares of Agile MV, a Montréal-based medical device design and development contract manufacturing company. The transaction was motivated by the quality of expertise that Agile MV's team of engineers, scientists, and technicians possess throughout the entire production cycle, from initial concept consolidation to mass production. Our partner, Audrey Gibeault, had the privilege of representing the company in this major transaction that involved complex tax planning, among other things. In business law, this transaction was led by our partner Étienne Brassard. Ms. Gibeault and Mr. Étienne Brassard were mainly assisted in this transaction by Gabrielle Ahélo. They were assisted by Luc Pariseau, Sonia Guérin, France Camille De Mers, Brittany Carson, Éric Gélinas, André Vautour, Michael Pageau, Maxime Chabot and Charles-Hugo Gagné. —Agile MV is a Quebec-based medical device design and development contract manufacturing company. It specializes in the development of minimally invasive diagnostic and therapeutic medical devices in the following areas: cardiac electrophysiology, interventional cardiology, interventional radiology, interventional pulmonology, interventional gastroenterology, interventional pain management and interventional neurology.Resonetics specializes in advanced engineering and manufacturing solutions for the life sciences industry, laser cutting, centerless grinding, nitinol processing, thin-wall stainless steel and precious metal tubing, photochemical machining, microfluidics, sensor solutions and medical energy.
-
Four new members join Lavery's ranks
Lavery is pleased to welcome three new associates to the Quebec City, Montreal and Sherbrooke offices: Philippe Brassard, Michaël Deslauriers and Anne-Philippe Pelchat. As well as a senior notary, Julie Doan, in the Montreal office. Anne-Philippe Pelchat Anne-Philippe is joining the Business Law group. She supports our partners and experienced members mainly in corporate reorganizations, mergers and acquisitions of private companies and the drafting of joint venture agreements. "I chose to join the Lavery family to have the opportunity to work with and learn from top-notch professionals who are passionate about their work. Business law has always been my field of choice and Lavery is, in my opinion, the ideal firm for young lawyers such as myself to achieve their ambitions and get professional development support. I also found the firms' values, the collaboration between colleagues and the constant willingness to improve very appealing." Julie Doan Julie Doan is part of Lavery’s Business Law group, where she practices real estate law. "The world of notaries is constantly evolving and I am very grateful to continue to be part of this dynamic and rewarding community with Lavery. I am confident that the expertise I have developed over the years in real estate law, combined with Lavery's, will be beneficial in serving our clients." Michaël Deslauriers Michaël is joining the Litigation and Dispute Resolution group. He is mainly involved in class actions and civil liability lawsuits. "Lavery is a firm that combines excellence, passion and modernity.It is therefore the perfect opportunity for me to continue to develop my expertise in civil law by getting involved in large-scale mandates and having experienced experts in the area as mentors. I was pleasantly surprised by the human face of the firm, which stands out by its involvement in the community and the attention it gives to its team." Philippe Brassard Philippe is joining the Business Law group. He supports our partners and experienced members mainly in matters involving early-stage companies, the technology sector and institutional investor financing. "It is first and foremost Lavery's culture of excellence, which can be seen through the quality of expertise of the firm's professionals, that led me to join the team. I was also impressed by the approachability of each member whom I met during my hiring process. The firm is dynamic and composed of passionate professionals. All in all, it is an ideal firm for a young lawyer to develop professionally."
-
Lavery assists Premier Parks LLC in the purchase of Calypso-Valcartier Group’s shares
On June 2, 2022, Calypso-Valcartier Group announced the sale of all of the shares of its two amusement parks, Village Vacances Valcartier located near Quebec City and Calypso, near Ottawa, and more specifically of the shares of the two parks’ operating corporations and their asset holding corporations. The assets of the two parks are now indirectly owned by EPR Properties, and they are operated by a Canadian subsidiary of Premier Parks, LLC. Our partners, André Vautour and France Camille De Mers, and their team assisted Premier Parks LLC in the due diligence of the parks’ assets and operations. They participated in structuring the new parks’ operating corporations, in the drafting of the share acquisition documentation of both the asset holding and operating corporations, and in the negotiation of all associated terms. The transaction was realized in collaboration with the Tennessee-based law firm Waller, a member, as is Lavery, of World Services Group, a worldwide network of premier law and other professional firms.
-
Catherine Deslauriers, Guy Lavoie, Éric Thibaudeau and Lavery named as a reference by the 2022 Canadian Occupational Safety – 5-Star Safety Lawyers & Law Firms
July 12, 2022 – Catherine Deslauriers, Guy Lavoie, Eric Thibaudeau and Lavery have been named as a reference in Occupational Health and Safety by Canadian Occupational Safety – 5-Star Safety Lawyers & Law Firms. To determine the best lawyers and law firms catering to the safety industry, Canadian Occupational Safety sourced feedback from safety leaders over a period of 15 weeks. COS’s research team began by conducting a survey with a wide range of safety officers to determine what companies value in the law firms they collaborate with.
-
Lavery supports the development of local e-commerce
On June 20, 2022, the Government of Québec and Plateforme Agora (now doing business as Le Panier Bleu) announced that Le Panier Bleu is transitioning to a private enterprise with the support of Quebec industry leaders. During the announcement, it was also confirmed that Le Panier Bleu will soon develop a transactional e-commerce platform making it possible to buy products from local merchants online. Lavery had the privilege of assisting Plateforme Agora in this round of financing and in Le Panier Bleu’s transition by providing advice on corporate financing, mergers and acquisitions, corporate law, intellectual property, commercial law in the field of technology and labour law. The Lavery team led by Étienne Brassard was composed of Jean-François Maurice, Isabelle Jomphe, Guillaume Laberge, Jessica Parent, Béatrice Bull, Isabelle Normand and Pamela Cifola.
-
-
Lexpert Recognizes Two Partners as Leading Infrastructures Lawyers in Canada
On June 16, 2022, Lexpert recognized the expertise of two of our partners in its 2022 Lexpert Special Edition: Infrastructure. Nicolas Gagnon and André Vautour now rank among Canada’s leaders in the area of infrastructure law. Nicolas Gagnon specializes in construction law and surety law. He counsels public and private sector clients, professional services firms and contractors as well as surety companies at every stage of construction projects. He advises clients with respect to the public bidding and procurement process, and is involved in the drafting of contract documents and the management of the work and any claims resulting therefrom. André Vautour practices in the fields of corporate and commercial law and is particularly interested in corporate governance, strategic alliances, joint ventures, investment funds and mergers and acquisitions of private corporations. He practises also in the field of technology law (drafting technology development and transfer agreements, licensing agreements, distribution agreements, outsourcing agreements, and e-commerce agreements).
-
Lexpert Recognizes Two Partners as Leading Technology Lawyers in Canada
On June 16, 2022, Lexpert recognized the expertise of two of our partners in its 2022 Lexpert Special Edition: Technology. Chantal Desjardins and André Vautour now rank among Canada’s leaders in the area of technology law. Chantal Desjardins is a partner, lawyer and trade-mark agent in Lavery’s intellectual property group. She contributes actively to the development of her clients’ rights in this field, which includes the protection of trade-marks, industrial designs, copyright, trade secrets, domain names and other related forms of intellectual property, in order to promote her clients’ business goals. André Vautour practices in the fields of corporate and commercial law and is particularly interested in corporate governance, strategic alliances, joint ventures, investment funds and mergers and acquisitions of private corporations. He practises also in the field of technology law (drafting technology development and transfer agreements, licensing agreements, distribution agreements, outsourcing agreements, and e-commerce agreements).
-
-
-
-
Lavery supports Domain Therapeutics in obtaining US $42M in financing
On May 10, 2022, Domain Therapeutics, a Franco-Canadian biopharmaceutical corporation specializing in research and development of innovative immuno-oncology treatments, announced the close of a US $42 million Series A financing round. This investment is a major step in the Franco-Canadian firm’s growth that aims to provide cancer patients with treatment solutions to overcome GPCR-mediated immunosuppression mechanisms. Mr. Alain Dumont, a partner at Lavery, had the privilege of supporting the corporation through this important transaction. Throughout his long-standing relationship with Domain Therapeutics, Mr. Dumont has lent his expertise to protect the company’s technologies and innovations by answering questions from investors, in particular. Lavery is immensely proud of Mr. Dumont’s work in securing this funding. — Domain Therapeutics, a biopharmaceutical company, based in France and Canada, is dedicated to discovering and developing novel medicine candidates targeting G-protein-coupled receptors (GPCRs), a key drug target class. The company focuses on producing high value-added immuno-oncology drug candidates.